• Home
  • About us
    • Mission
    • The Board’s Presentation
  • News
    • What’s New on CytoPrevent
    • Board’s Position Papers
  • Guidelines & Regulations
  • Resources
    • Studies
    • Videos
    • Useful Links
  • Events
    • Congresses
  • Contact
USP800 in brief – USP800 en résumé

USP800 in brief – USP800 en résumé

by CytoPrevent | Dec 11, 2021 | Guidelines & Regulations

Abstract: What is a CSTD? A CSTD or closed system drug transfer device mechanically prohibits the transfer of environmental contaminants into the system and the escape of hazardous drugs (HD’s) or vapor concentrations outside the system. Does USP 800 require the use...
US: Closed-system transfer-devices for limiting exposure to cytotoxic anti-cancer drugs in healthcare professionals, patients and visitors

US: Closed-system transfer-devices for limiting exposure to cytotoxic anti-cancer drugs in healthcare professionals, patients and visitors

by CytoPrevent | Mar 1, 2021 | Guidelines & Regulations

What were we asked to look at? NHS Forth Valley asked us to review the evidence on the effectiveness of closed-system transfer-devices (CSTDs) in reducing the risk of exposure to hazardous anti-cancer drug treatments in healthcare professionals (all relevant staff...
Spain: Exposición laboral a citostáticos en el ámbito sanitario

Spain: Exposición laboral a citostáticos en el ámbito sanitario

by CytoPrevent | Feb 15, 2021 | Guidelines & Regulations

Xavier Guardino Solá, Gracia Rosell Farrás, Míriam Galisteo Manzanares   Abstract: Los citostáticos son sustancias citotóxicas diseñadas y utilizadas para causar disfunción celular, inhibiendo el crecimiento de las células cancerosas mediante la alteración del...
USA: Niosh Alert – Preventing Occupational Exposures To Antineoplastic and Other Hazardous Drugs in Health Care Settings

USA: Niosh Alert – Preventing Occupational Exposures To Antineoplastic and Other Hazardous Drugs in Health Care Settings

by CytoPrevent | Feb 15, 2021 | Guidelines & Regulations

The National Institute for Occupational Safety and Health (NIOSH) requests assistance in preventing occupational exposures to antineoplastic drugs (drugs used to treat cancer) and other hazardous drugs in health care settings. Healthcare workers who work with or near...
Spain: Guía de Buenas Prácticas Para Trabajadores Profesionalmente Expuestos A Agentes Citostáticos

Spain: Guía de Buenas Prácticas Para Trabajadores Profesionalmente Expuestos A Agentes Citostáticos

by CytoPrevent | Feb 10, 2021 | Guidelines & Regulations

Introducción: Desde el principio, se planteó como objetivo principal del grupo de trabajo la elaboración de una guía en la que se pudiese justificar la necesidad de revisión de la Orden 22 de abril de 1992 de la Comunidad de Madrid, normativa vigente en la actualidad,...
Australia: Cytotoxic drugs and related waste – Risk management

Australia: Cytotoxic drugs and related waste – Risk management

by CytoPrevent | Feb 2, 2021 | Guidelines & Regulations

Purpose This guide provides practical advice to PCBUs and workers on how to prevent or minimise the risks to health associated with handling cytotoxic drugs and related waste within health care establishments, community settings and veterinary practices. It will...
« Older Entries

Legal Mentions

Cookies Policy

Contact Us


Follow us on Twitter

ESMO

 

Loading Comments...